These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 7519208

  • 1. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB, Kropshofer H, Kalbacher H, Kalbus M, Rammensee HG, Coligan JE, Martin R.
    J Immunol; 1994 Aug 15; 153(4):1665-73. PubMed ID: 7519208
    [Abstract] [Full Text] [Related]

  • 2. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y, Li H, Martin R, Mariuzza RA.
    J Mol Biol; 2000 Nov 24; 304(2):177-88. PubMed ID: 11080454
    [Abstract] [Full Text] [Related]

  • 3. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, Hochberger M, Albert ED, Adorini L.
    J Clin Invest; 1993 Feb 24; 91(2):616-28. PubMed ID: 7679413
    [Abstract] [Full Text] [Related]

  • 4. Several common HLA-DR types share largely overlapping peptide binding repertoires.
    Southwood S, Sidney J, Kondo A, del Guercio MF, Appella E, Hoffman S, Kubo RT, Chesnut RW, Grey HM, Sette A.
    J Immunol; 1998 Apr 01; 160(7):3363-73. PubMed ID: 9531296
    [Abstract] [Full Text] [Related]

  • 5. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.
    Kropshofer H, Max H, Halder T, Kalbus M, Muller CA, Kalbacher H.
    J Immunol; 1993 Nov 01; 151(9):4732-42. PubMed ID: 8409432
    [Abstract] [Full Text] [Related]

  • 6. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H, Dengjel J, de Graaf KL, Wiesmüller KH, Stevanović S, Weissert R.
    Immunogenetics; 2005 Apr 01; 57(1-2):69-76. PubMed ID: 15711804
    [Abstract] [Full Text] [Related]

  • 7. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
    Bach JM, Otto H, Nepom GT, Jung G, Cohen H, Timsit J, Boitard C, van Endert PM.
    J Autoimmun; 1997 Aug 01; 10(4):375-86. PubMed ID: 9237801
    [Abstract] [Full Text] [Related]

  • 8. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M, Kalbus M, Rojo SC, Hemmer B, Kalbacher H, Tranquill L, Beck H, McFarland HF, De Mars R, Long EO, Martin R.
    J Neuroimmunol; 1997 Aug 01; 77(2):195-203. PubMed ID: 9258250
    [Abstract] [Full Text] [Related]

  • 9. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles.
    Kirschmann DA, Duffin KL, Smith CE, Welply JK, Howard SC, Schwartz BD, Woulfe SL.
    J Immunol; 1995 Dec 15; 155(12):5655-62. PubMed ID: 7499850
    [Abstract] [Full Text] [Related]

  • 10. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DA, Strominger JL.
    Nature; 1992 Aug 27; 358(6389):764-8. PubMed ID: 1380674
    [Abstract] [Full Text] [Related]

  • 11. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
    Davenport MP, Quinn CL, Chicz RM, Green BN, Willis AC, Lane WS, Bell JI, Hill AV.
    Proc Natl Acad Sci U S A; 1995 Jul 03; 92(14):6567-71. PubMed ID: 7604034
    [Abstract] [Full Text] [Related]

  • 12. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions.
    Sette A, Sidney J, Oseroff C, del Guercio MF, Southwood S, Arrhenius T, Powell MF, Colón SM, Gaeta FC, Grey HM.
    J Immunol; 1993 Sep 15; 151(6):3163-70. PubMed ID: 7690794
    [Abstract] [Full Text] [Related]

  • 13. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hämmerling GJ.
    EMBO J; 1996 Nov 15; 15(22):6144-54. PubMed ID: 8947036
    [Abstract] [Full Text] [Related]

  • 14. Human TCR as antigen: homologies and potentially cross-reactive HLA-DR2-restricted epitopes within the AV and BV CDR2 loops.
    Vandenbark AA, Culbertson N, Finn T, Barnes D, Buenafe A, Burrows GG, Law S, Chou YK, Offner H.
    Crit Rev Immunol; 2000 Nov 15; 20(1):57-83. PubMed ID: 10770270
    [Abstract] [Full Text] [Related]

  • 15. The HLA-DP2 protein binds the immunodominant epitope from myelin basic protein, MBP85-99, with high affinity.
    Hansen BE, Nielsen CH, Madsen HO, Ryder LP, Jakobsen BK, Svejgaard A.
    Tissue Antigens; 2011 Mar 15; 77(3):229-34. PubMed ID: 21299528
    [Abstract] [Full Text] [Related]

  • 16. Prediction of peptide affinity to HLA DRB1*0401.
    Marshall KW, Wilson KJ, Liang J, Woods A, Zaller D, Rothbard JB.
    J Immunol; 1995 Jun 01; 154(11):5927-33. PubMed ID: 7751636
    [Abstract] [Full Text] [Related]

  • 17. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401.
    Hill CM, Liu A, Marshall KW, Mayer J, Jorgensen B, Yuan B, Cubbon RM, Nichols EA, Wicker LS, Rothbard JB.
    J Immunol; 1994 Mar 15; 152(6):2890-8. PubMed ID: 8144889
    [Abstract] [Full Text] [Related]

  • 18. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JB.
    J Immunol; 1991 Aug 15; 147(4):1292-8. PubMed ID: 1869824
    [Abstract] [Full Text] [Related]

  • 19. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U, Meyerhans A.
    Eur J Immunol; 1993 Jun 15; 23(6):1271-6. PubMed ID: 7684684
    [Abstract] [Full Text] [Related]

  • 20. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP, Jones RE, Rich C, Dahan R, Link J, David CS, Chou YK, Offner H, Vandenbark AA.
    J Neurosci Res; 2004 Oct 01; 78(1):100-14. PubMed ID: 15372502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.